The rating affirmation is based a variety of factors, including the organization’s clinical excellence, broad footprint, strong operating performance and strong liquidity.
Moody’s also assigned an “Aa3/VMIG1” rating to UCHA’s proposed $116 million of series 2017B variable-rate demand bonds, and affirmed the “Aa3” rating on the organization’s outstanding debt.
The outlook is stable, reflecting Moody’s Investors Service’s expectation UCHA’s overall performance will remain strong.
More articles on healthcare finance:
9 recent hospital outlook and credit rating actions
Moody’s affirms ‘A1’ rating on Phoebe Putney Memorial Hospital’s bonds
Fitch assigns ‘BB+’ rating to Orange Regional Medical Center bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
